Kangmei Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600518.SS

Kangmei Pharmaceutical Co., Ltd. Market Capitalization on January 14, 2025: USD 4.23 B

Kangmei Pharmaceutical Co., Ltd. Market Capitalization is USD 4.23 B on January 14, 2025, a 118.58% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Kangmei Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 5.46 B on December 09, 2024, which is 28.92% above the current Market Capitalization.
Kangmei Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 1.80 B on June 25, 2024, which is -57.50% below the current Market Capitalization.
Kangmei Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 2.84 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shanghai Stock Exchange: 600518.SS

Kangmei Pharmaceutical Co., Ltd.

CEO	Mr. Guowei Liu
IPO Date	March 19, 2001
Location	China
Headquarters	East side of Jieshen Road
Employees	4,409
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.

Key trends

Past 5 years